This morning, Johnson & Johnson shared its fourth-quarter and full-year 2025 earnings report.
Since its founding in 1886, the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.
“Johnson & Johnson exceeded expectations in 2025, not just with our financial results, but with the continued expansion of our product portfolio that addresses some of healthcare’s greatest needs,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We elevated investments in manufacturing, research and development and technology to ensure the future is even more robust, with line of sight to double-digit growth in the latter years of this decade. We enter 2026 with strong momentum that will deliver better patient outcomes and create long‑term value for our shareholders.”
For more details about the company’s full-year 2025 results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
